Clinical Trial

Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study is aiming to evaluate safety, efficacy and durability of intracavernosal injection (ICI) of Botulinum toxin A plus oral tadalafil in controlled diabetic men with refractory Erectile Dysfunction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-31.
Trial Details
NCT Number NCT06583590
Lead Sponsor Aswan University Hospital
Collaborators: Aswan University, Cairo University
Conditions Erectile Dysfunction With Diabetes Mellitus
Enrollment 32 participants
Start Date 2024-08-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-03